Stock Activity: Taylor Morrison Home Corporation (NYSE:TMHC), Clearwater Paper Corporation (NYSE:CLW), FibroGen (NASDAQ:FGEN), CEL-SCI Corporation (NYSEMKT:CVM)

Barracuda Networks, Inc. (NYSE:CUDA) shares decreased -2.07% in last trading session and ended the day at $15.58. CUDA Gross Margin is 78.60% and its has a return on assets of -18.50%. Barracuda Networks, Inc. (NYSE:CUDA) quarterly performance is 48.38%.

Barracuda Networks, Inc. (NYSE:CUDA), a leading provider of cloud-connected security and storage solutions, announced that it will report its financial results for the fourth quarter and fiscal year ended February 29, 2016, following the close of the market on Tuesday, April 26, 2016. On that day, management will host a conference call and webcast at 1:30 p.m. PT to review and discuss the Company’s results.

Taylor Morrison Home Corporation (NYSE:TMHC) ended the last trading day at $15.14. Company weekly volatility is calculated as 2.71% and price to cash ratio as 14.72. Taylor Morrison Home Corporation (NYSE:TMHC) showed a weekly performance of 3.20%.

Two new Home Corporation (NYSE:TMHC)coastal communities by Taylor Morrison, a leading national homebuilder and developer, are coming soon to Southern California with the grand openings of Cottages at St. Cloud in Oceanside and Lighthouse in Costa Mesa in April.

On 15 April, Clearwater Paper Corporation (NYSE:CLW) shares increased 0.66% and was closed at $51.74. CLW EPS growth in last 5 year was -0.90%. Clearwater Paper Corporation (NYSE:CLW) year to date (YTD) performance is 13.64%.

Clearwater Paper Corporation (NYSE:CLW) announced that it will host its first quarter 2016 earnings conference call and webcast on Thursday, April 28, 2016, at 2 p.m. Pacific Daylight Time.

FibroGen, Inc. (NASDAQ:FGEN) shares increased 0.29% in last trading session and ended the day at $20.42. FGEN has a return on assets of -17.60%. FibroGen, Inc. (NASDAQ:FGEN) quarterly performance is -14.92%.

FibroGen, Inc. (NASDAQ:FGEN) announced that as of April 1, 2016, K. Peony Yu, M.D., the Company’s Vice President of Clinical Development, has been appointed as Chief Medical Officer, succeeding Frank Valone, M.D. Dr. Valone has decided to step down and will remain with the Company, transitioning to the role of Senior Fellow, Clinical Development and retaining responsibility for a portion of his prior duties.

CEL-SCI Corporation (NYSEMKT:CVM) caters to the Healthcare space. Its weekly performance is -5.92%. On the last day of trading company shares ended up at $0.56. CEL-SCI Corporation (NYSEMKT:CVM) distance from 50-day simple moving average (SMA50) is 0.78%.

CEL-SCI Corporation (NYSE MKT:CVM) announced that its CEO, Geert Kersten, was recently interviewed on The RedChip Money Report television program. The interview air Sunday, April 10, at 11:00 a.m. ET on Newsmax TV, available in 40 million homes via DIRECTV, DISH Network, and Verizon FiOS.